• Treffer 8 von 15
Zurück zur Trefferliste

Intestinal acid sphingomyelinase protects from severe Pathogen-Driven Colitis

  • Inflammatory diseases of the gastrointestinal tract are emerging as a global problem with increased evidence and prevalence in numerous countries. A dysregulated sphingolipid metabolism occurs in patients with ulcerative colitis and is discussed to contribute to its pathogenesis. In the present study, we determined the impact of acid sphingomyelinase (Asm), which catalyzes the hydrolysis of sphingomyelin to ceramide, on the course of Citrobacter (C.) rodentium-driven colitis. C. rodentium is an enteric pathogen and induces colonic inflammation very similar to the pathology in patients with ulcerative colitis. We found that mice with Asm deficiency or Asm inhibition were strongly susceptible to C. rodentium infection. These mice showed increased levels of C. rodentium in the feces and were prone to bacterial spreading to the systemic organs. In addition, mice lacking Asm activity showed an uncontrolled inflammatory T(h)1 and T(h)17 response, which was accompanied by a stronger colonic pathology compared to infected wild type mice.Inflammatory diseases of the gastrointestinal tract are emerging as a global problem with increased evidence and prevalence in numerous countries. A dysregulated sphingolipid metabolism occurs in patients with ulcerative colitis and is discussed to contribute to its pathogenesis. In the present study, we determined the impact of acid sphingomyelinase (Asm), which catalyzes the hydrolysis of sphingomyelin to ceramide, on the course of Citrobacter (C.) rodentium-driven colitis. C. rodentium is an enteric pathogen and induces colonic inflammation very similar to the pathology in patients with ulcerative colitis. We found that mice with Asm deficiency or Asm inhibition were strongly susceptible to C. rodentium infection. These mice showed increased levels of C. rodentium in the feces and were prone to bacterial spreading to the systemic organs. In addition, mice lacking Asm activity showed an uncontrolled inflammatory T(h)1 and T(h)17 response, which was accompanied by a stronger colonic pathology compared to infected wild type mice. These findings identified Asm as an essential regulator of mucosal immunity to the enteric pathogen C. rodentium.zeige mehrzeige weniger

Metadaten exportieren

Weitere Dienste

Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Verfasserangaben:Jana MeinersGND, Vittoria Palmieri, Robert KlopfleischORCiDGND, Jana-Fabienne Ebel, Lukasz JaptokGND, Fabian SchumacherORCiDGND, Ayan Mohamud YusufGND, Katrin Anne BeckerORCiDGND, Julia ZöllerGND, Matthias HoseGND, Burkhard KleuserORCiDGND, Dirk Matthias HermannGND, Richard N. Kolesnick, Jan BuerGND, Wiebke HansenGND, Astrid M. WestendorfGND
DOI:https://doi.org/10.3389/fimmu.2019.01386
ISSN:1664-3224
Pubmed ID:https://pubmed.ncbi.nlm.nih.gov/31275322
Titel des übergeordneten Werks (Englisch):Frontiers in immunology
Verlag:Frontiers Research Foundation
Verlagsort:Lausanne
Publikationstyp:Wissenschaftlicher Artikel
Sprache:Englisch
Datum der Erstveröffentlichung:19.06.2019
Erscheinungsjahr:2019
Datum der Freischaltung:20.01.2021
Freies Schlagwort / Tag:Citrobacter rodentium; T(h)1; T(h)17; acid sphingomyelinase; amitriptyline; colitis
Band:10
Seitenanzahl:14
Fördernde Institution:Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG-GRK2098, GRK1949]
Organisationseinheiten:Mathematisch-Naturwissenschaftliche Fakultät / Institut für Biochemie und Biologie
DDC-Klassifikation:5 Naturwissenschaften und Mathematik / 57 Biowissenschaften; Biologie / 570 Biowissenschaften; Biologie
Peer Review:Referiert
Publikationsweg:Open Access / Gold Open-Access
DOAJ gelistet
Lizenz (Deutsch):License LogoCC-BY - Namensnennung 4.0 International
Verstanden ✔
Diese Webseite verwendet technisch erforderliche Session-Cookies. Durch die weitere Nutzung der Webseite stimmen Sie diesem zu. Unsere Datenschutzerklärung finden Sie hier.